These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas]. Nikolov A; Karag'ozov I Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353 [TBL] [Abstract][Full Text] [Related]
44. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638 [TBL] [Abstract][Full Text] [Related]
45. Hysterectomy for benign uterine pathology among women without previous vaginal delivery. Tohic AL; Dhainaut C; Yazbeck C; Hallais C; Levin I; Madelenat P Obstet Gynecol; 2008 Apr; 111(4):829-37. PubMed ID: 18378741 [TBL] [Abstract][Full Text] [Related]
46. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial. Chang FW; Yu MH; Ku CH; Chen CH; Wu GJ; Liu JY BJOG; 2006 Jan; 113(1):47-52. PubMed ID: 16398771 [TBL] [Abstract][Full Text] [Related]
47. Laparoscopically-assisted vaginal hysterectomy (LAVH)--an alternative to abdominal hysterectomy. Devendra K; Tay SK Singapore Med J; 2002 Mar; 43(3):138-42. PubMed ID: 12005340 [TBL] [Abstract][Full Text] [Related]
48. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist. Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701 [TBL] [Abstract][Full Text] [Related]
49. Uterine weight as a predictor of morbidity after a benign abdominal and total laparoscopic hysterectomy. Bonilla DJ; Mains L; Whitaker R; Crawford B; Finan M; Magnus M J Reprod Med; 2007 Jun; 52(6):490-8. PubMed ID: 17694966 [TBL] [Abstract][Full Text] [Related]
50. [Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period]. Russo P; Ciolli P; Atlante M; Carico E; Mancini R; Russo R; Vecchione A Minerva Ginecol; 1998 Nov; 50(11):499-502. PubMed ID: 9882992 [TBL] [Abstract][Full Text] [Related]
51. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
52. Preoperative assessment by magnetic resonance imaging is useful for planning the treatment of an enlarged uterus by total laparoscopic hysterectomy. Hatta K; Terai Y; Okuda K; Nakamura Y; Yoo S; Tanaka Y; Tsunetoh S; Hayashi A; Yamashita Y; Ohmichi M J Obstet Gynaecol Res; 2013 Apr; 39(4):814-9. PubMed ID: 23379476 [TBL] [Abstract][Full Text] [Related]
53. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. Benassi L; Rossi T; Kaihura CT; Ricci L; Bedocchi L; Galanti B; Vadora E Am J Obstet Gynecol; 2002 Dec; 187(6):1561-5. PubMed ID: 12501064 [TBL] [Abstract][Full Text] [Related]
54. Preoperative use of GnRH agonist for leiomyomas. Hutchins FL J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502 [No Abstract] [Full Text] [Related]
55. Vaginal versus abdominal hysterectomy for the enlarged non-prolapsed uterus: a retrospective cohort study. Fatania K; Vithayathil M; Newbold P; Yoong W Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():111-4. PubMed ID: 24412144 [TBL] [Abstract][Full Text] [Related]
56. Recovery from vaginal hysterectomy compared with laparoscopy-assisted vaginal hysterectomy: a prospective, randomized, multicenter study. Soriano D; Goldstein A; Lecuru F; Daraï E Acta Obstet Gynecol Scand; 2001 Apr; 80(4):337-41. PubMed ID: 11264609 [TBL] [Abstract][Full Text] [Related]
57. [Effects of buserelin presurgical treatment on vascularity in the sub-serosal interstitial tissue of the uterus and operative blood loss at hysterectomy in women with uterine leiomyoma and adenomyosis]. Morita Y; Kojima T; Takeda S; Kinoshita K; Sakamoto S; Baba K; Itoyama S Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):197-204. PubMed ID: 1901583 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Friedman AJ; Lobel SM; Rein MS; Barbieri RL Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765 [TBL] [Abstract][Full Text] [Related]
59. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Zullo F; Pellicano M; De Stefano R; Zupi E; Mastrantonio P Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812 [TBL] [Abstract][Full Text] [Related]
60. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas. Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]